Front Page
 

Blue Cross Medicare AdvantageSM wellness benefits
Researchers discover mutated gene that prevents diabetes
Medical ID bracelets can save your life
Get preferred pricing at these pharmacies
Save with generic drugs
Get a free workout booklet
Blue365 deal: Walkadoo
 

Fight diabetes with good nutrition
Tips for taking your medicine right
6 paths to a happier life
Get moving for better health
 
Beware of food-drug interactions
Antioxidants for good health
Protect your eyes from the sun
 
Is it more than a senior moment?
Tips for bolstering your memory
How to get more for your vacation bucks
Readers' stories of retiring and finding themselves anew
Drug companies collaborate on research
China's Terra Cotta Warriors come to Indianapolis
'LifeTimes' wins design award
Learn about Hope Paige, maker of fashionable medical ID bracelets
Learn about HealthWays, creator of the Walkadoo social walking program
BCBSTX social responsibility report
BCBSTX 'Blue Zones' grant to Fort Worth
Your letters to "LifeTimes"
 
 
Play our 'Mystery Game'
Crossword puzzle
Sudoku puzzle
Word search puzzle
 
 
Medicare Basics
Recent News
Current Issue
Previous Issues
About LifeTimes Newsletter
Sign up for LifeTimes email updates
 


  facebook twitter youtube
  Learn more


 
Share |
Latest News

FDA issues update on osteoporosis drugs

Heart Health

Bisphosphonates, drugs used effectively to treat osteoporosis, have been widely prescribed since 1995. But questions linger about possible problems with their long-term use. (Prescribed under several brand names as well as generics, bisphosphonates carry safety warnings about potential risks for jawbone decay and thigh bone fractures.)

Now, an update on the U.S. Food and Drug Administration’s Consumer Updates website suggests some bisphosphonate users may be able to stop taking the drugs after three to five years, yet keep benefiting from their use, because the drugs can stay in bones for years.

FDA researchers base their report on a survey of clinical studies involving bone mineral density and fractures in men and women who had been taking bisphosphonates for three to 10 years.

(NOTE: Researchers stress highly more investigation is needed, and osteoporosis patients taking bisphosphonates should consult their doctors about specific health needs.)

For example, "Patients at increased risk for fractures (like older patients with a history of fracture and sub-normal bone density) may benefit further from continued bisphosphonate therapy," the FDA says.

To read the full report, "How Long Should You Take Osteoporosis Drugs?" visit www.fda.gov, click on "For Consumers and Patients," then search for "osteoporosis."